WorthPointe’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
II
BFS
OFS
CW
PFG
PAW
WorthPointe's IBD Position: Q1 2026 in Review
WorthPointe reduced its Inspire Corporate Bond ETF (IBD) stake by 34% in Q1 2026, selling an estimated $2.54M and leaving 206,967 shares worth $4.94M. The position accounts for 1.34% of the portfolio, ranked #18.
WorthPointe first reported a position in IBD in Q3 2023 and has held it in 4 quarters since. The position peaked at $7.56M in Q4 2025. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.
- WorthPointe held 206,967 shares of Inspire Corporate Bond ETF worth $4.94M as of Q1 2026.
- WorthPointe sold 105,329 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $2.54M.
- Inspire Corporate Bond ETF made up 1.34% of WorthPointe's portfolio in Q1 2026, its #18 holding.
- WorthPointe first reported a position in Inspire Corporate Bond ETF in Q3 2023 and has held it in 4 quarters since.
- WorthPointe's Inspire Corporate Bond ETF position peaked at $7.56M in Q4 2025.
- 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.
Based on WorthPointe's 13F filing for Q1 2026, filed 12 May 2026.